gvtcx

Supply of Potency Assay Services for RNA and RNA‑LNP products

CENTRE FOR PROCESS INNOVATION LIMITED Published 15 Apr 2026 Find a Tender
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£300,000 (£360,000 inc. VAT)
Statusactive
Category (CPV) 71900000 +3 more
Deadline15 May 2026
Procedureopen
OCIDocds-h6vhtk-06835b

description

This tender seeks to engage a qualified service provider to perform cell based, in vitro potency assays for the quantification of both RNA (drug substance) and RNA-LNP (Lipid Nanoparticle) (drug product) activity. The assays will be used to evaluate the biological functionality of RNA-LNP formulations, ensuring consistency and efficacy during production.

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
15 Apr 2026 Tender notice (UK4) Procurement Act 2023 034352-2026
15 Apr 2026 Tender notice (UK4) Procurement Act 2023 034357-2026

more from CENTRE FOR PROCESS INNOVATION LIMITED

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.